Heart failure & cardiomyopathies

Health-Related Quality of Life Across Heart Failure Categories: Associations with Clinical Characteristics and Outcomes

ESC Heart FailPublished Registry study

Authors' conclusion

Most patients were in the two highest EQ 5D-vas categories. Higher NYHA class had the strongest association with lower EQ 5D-vas categories, across all EF categories. Patients in the worst EQ 5D-vas category were at the highest risk of mortality.

Study context

Population
Patients with heart failure (HF) with preserved, mildly reduced and reduced ejection fraction (HFpEF, HFmrEF and HFrEF) in the Swedish Heart Failure Registry (SwedeHF; 2000–2021)median age 74 years, 32% female
Participants
40,809 patients
Exposure
Associations between patients' characteristics and EQ 5D-vas, and between EQ 5D-vas and outcomes
Outcome
Distribution of EQ 5D-vas categories
Follow-up
Baseline

Main finding

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeAdjusted hazard ratio (95% CI)
All-cause death'worst'vs 'best'HFrEF1.97 (1.64–2.37)
All-cause death'worst'vs 'best'HFmrEF1.77 (1.30–2.40)
All-cause death'worst'vs 'best'HFpEF1.43 (1.02–2.00)

Characteristics associated with lower EQ 5D-vas

Higher New York Heart Association (NYHA) class strongly associated with lower EQ 5D-vas regardless of ejection fraction (EF) categories, followed by chronic obstructive pulmonary disease, smoking, body mass index, higher heart rate, anaemia, previous stroke, ischaemic heart disease, use of diuretics and living alone
Higher income, male sex, outpatient status and higher systolic blood pressure inversely associated with lower EQ 5D-vas categories

Original publication

Health-Related Quality of Life Across Heart Failure Categories: Associations with Clinical Characteristics and Outcomes. ESC Heart Fail. Published 27 January 2025. doi:10.1002/ehf2.15206

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.